SouthState Bank Corp Sells 4,322 Shares of Danaher Corporation $DHR

SouthState Bank Corp trimmed its stake in shares of Danaher Corporation (NYSE:DHRFree Report) by 4.1% during the third quarter, HoldingsChannel.com reports. The firm owned 100,652 shares of the conglomerate’s stock after selling 4,322 shares during the quarter. Danaher makes up 0.9% of SouthState Bank Corp’s portfolio, making the stock its 25th largest position. SouthState Bank Corp’s holdings in Danaher were worth $19,955,000 at the end of the most recent quarter.

A number of other hedge funds have also added to or reduced their stakes in the stock. WFA of San Diego LLC bought a new position in shares of Danaher in the second quarter valued at approximately $26,000. Howard Hughes Medical Institute bought a new position in Danaher in the 2nd quarter valued at $27,000. TruNorth Capital Management LLC purchased a new position in shares of Danaher during the 3rd quarter valued at $28,000. Tripletail Wealth Management LLC bought a new position in shares of Danaher in the third quarter worth $31,000. Finally, Heartwood Wealth Advisors LLC purchased a new stake in shares of Danaher in the third quarter worth $37,000. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages have weighed in on DHR. Leerink Partners upped their target price on Danaher from $260.00 to $270.00 and gave the stock an “outperform” rating in a research note on Friday, January 16th. JPMorgan Chase & Co. upped their price objective on shares of Danaher from $270.00 to $275.00 and gave the stock an “overweight” rating in a research report on Thursday, January 29th. Evercore ISI reiterated an “outperform” rating and set a $254.00 target price on shares of Danaher in a research report on Wednesday, January 28th. Jefferies Financial Group increased their price target on shares of Danaher from $255.00 to $265.00 and gave the stock a “buy” rating in a report on Wednesday, January 28th. Finally, Guggenheim lifted their price objective on shares of Danaher from $250.00 to $275.00 and gave the stock a “buy” rating in a report on Friday, January 2nd. Twenty analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $252.32.

View Our Latest Stock Analysis on DHR

Insider Activity at Danaher

In other news, SVP Georgeann Couchara sold 5,174 shares of the stock in a transaction that occurred on Monday, November 10th. The stock was sold at an average price of $210.42, for a total transaction of $1,088,713.08. Following the completion of the sale, the senior vice president owned 2,625 shares of the company’s stock, valued at approximately $552,352.50. This represents a 66.34% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Teri List sold 3,298 shares of the firm’s stock in a transaction that occurred on Tuesday, November 18th. The stock was sold at an average price of $226.50, for a total transaction of $746,997.00. Following the completion of the transaction, the director owned 20,762 shares in the company, valued at $4,702,593. This represents a 13.71% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold 30,248 shares of company stock worth $6,609,663 in the last ninety days. 11.10% of the stock is owned by company insiders.

Danaher Trading Up 1.3%

Shares of DHR opened at $219.31 on Thursday. Danaher Corporation has a fifty-two week low of $171.00 and a fifty-two week high of $242.80. The firm has a market cap of $154.91 billion, a price-to-earnings ratio of 43.51, a PEG ratio of 2.93 and a beta of 0.91. The firm has a 50 day moving average price of $230.07 and a 200-day moving average price of $214.68. The company has a debt-to-equity ratio of 0.35, a quick ratio of 1.51 and a current ratio of 1.87.

Danaher (NYSE:DHRGet Free Report) last issued its earnings results on Wednesday, January 28th. The conglomerate reported $2.23 EPS for the quarter, topping analysts’ consensus estimates of $2.14 by $0.09. The company had revenue of $6.84 billion for the quarter, compared to analysts’ expectations of $6.79 billion. Danaher had a net margin of 14.71% and a return on equity of 10.81%. The firm’s revenue was up 4.6% compared to the same quarter last year. During the same quarter last year, the company earned $2.14 EPS. Danaher has set its FY 2026 guidance at 8.350-8.500 EPS. As a group, equities research analysts forecast that Danaher Corporation will post 7.63 earnings per share for the current year.

Danaher Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, January 30th. Stockholders of record on Friday, December 26th were paid a $0.32 dividend. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date of this dividend was Friday, December 26th. Danaher’s payout ratio is 25.40%.

Danaher Company Profile

(Free Report)

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

Read More

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHRFree Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.